Inventor
NAGATSUKA MASATO
JP13 patents
⚠️ This page may combine multiple inventors who share the name “NAGATSUKA MASATO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MATSUDA MAMORU
7 patentsUS8551991B2Oct 8, 2013
1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
MATSUDA MAMORU3 citations61
US8193187B2Jun 5, 2012
1,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activity
MATSUDA MAMORU3 citations60
US8580784B2Nov 12, 2013
Method for treating a disease related to the glucocorticoid receptor
MATSUDA MAMORU0 citations50
US8569493B2Oct 29, 2013
Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound
MATSUDA MAMORU1 citations50
US8563551B2Oct 22, 2013
Method for preventing or treating a disease related to the glucocorticoid receptor
MATSUDA MAMORU0 citations50
US8440660B2May 14, 2013
Method for treating a disease related to the glucocorticoid receptor
MATSUDA MAMORU0 citations50
US8420635B2Apr 16, 2013
Method for preventing or treating a glucocorticoid receptor-related disease
MATSUDA MAMORU0 citations50
SANTEN PHARMACEUTICAL CO LTD
6 patentsUS9676703B2Jun 13, 2017
Production method for 3,3-dimethyl-3,4-dihydro-1H-quinoxalin-2-one derivative and intermediate for said production method
SANTEN PHARMACEUTICAL CO LTD2 citations69
US8017775B2Sep 13, 2011
1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
SANTEN PHARMACEUTICAL CO LTD3 citations61
US8008498B2Aug 30, 2011
1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
SANTEN PHARMACEUTICAL CO LTD1 citations61
US8975256B2Mar 10, 2015
1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity
SANTEN PHARMACEUTICAL CO LTD0 citations51
US8008496B2Aug 30, 2011
1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
SANTEN PHARMACEUTICAL CO LTD0 citations51
US8008497B2Aug 30, 2011
1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
SANTEN PHARMACEUTICAL CO LTD0 citations51